- Motley Fool•2 hours ago
These three biotech stocks look poised to outperform.
- Investopedia•4 hours ago
Two failed acquisitions have cast a long shadow on Sanofi's prospects.
- TheStreet.com•3 days ago
Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.
REGN : Summary for Regeneron Pharmaceuticals, Inc. - Yahoo Finance
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||350.00 x 100|
|Ask||357.50 x 100|
|Day's Range||354.17 - 363.41|
|52 Week Range||325.35 - 482.27|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||51.70|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|